Metigalen (Methylprednisolone Aceponate)

Methylprednisolone aceponate penetrates the skin and binds to intracellular glucocorticoid receptors. The drug‑receptor complex alters gene transcription, suppressing pro‑inflammatory cytokines, inhibiting leukocyte migration and decreasing vascular permeability, which together produce potent anti‑inflammatory and immunosuppressive effects at the site of application.

The dosage of Metigalen is individualized by the prescribing clinician based on the severity of the skin condition, the area to be treated and patient age. Typical regimens involve applying a thin layer to the affected area once or twice daily for a limited period, but exact instructions must come from a qualified healthcare professional.

Safety data for methylprednisolone aceponate in pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Healthcare providers should weigh potential benefits against risks and consider alternative therapies when treating pregnant or nursing patients.

To request Metigalen, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Metigalen belongs to the class of potent topical corticosteroids, similar to betamethasone dipropionate or clobetasol propionate. Compared with lower‑potency steroids, it offers stronger anti‑inflammatory control for resistant lesions but carries a higher risk of local side effects such as skin atrophy, requiring careful monitoring and limited treatment duration.

Metigalen should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture and direct sunlight. Keep the container tightly closed when not in use and out of reach of children.

Metigalen is applied topically to clean, dry skin. A thin layer is spread over the affected area, usually once or twice daily, as directed by the prescriber. Hands should be washed before and after application, and the treated skin should not be covered with airtight dressings unless specifically advised.

Serious risks include adrenal suppression with extensive or prolonged use, severe allergic reactions such as angioedema or anaphylaxis, skin atrophy or striae, and secondary infections (bacterial, fungal or viral). Patients should report signs of systemic effects, unusual skin changes or persistent irritation to their healthcare provider promptly.

Metigalen is contraindicated in individuals with known hypersensitivity to methylprednisolone aceponate or any excipients, in skin that is infected, ulcerated or contains viral lesions (e.g., herpes simplex), and in patients receiving systemic corticosteroid therapy where additional local steroid exposure may be harmful.